Liver Diseases Therapeutics Market 2028 By Type of Treatment, End user | The Insight Partners

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Liver Diseases Therapeutics Market - By Type of Treatment
1.3.2 Liver Diseases Therapeutics Market - By End user
1.3.3 Liver Diseases Therapeutics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. LIVER DISEASES THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. LIVER DISEASES THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. LIVER DISEASES THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. LIVER DISEASES THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. LIVER DISEASES THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. LIVER DISEASES THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE OF TREATMENT
7.1. OVERVIEW
7.2. TYPE OF TREATMENT MARKET FORECASTS AND ANALYSIS
7.3. ANTIVIRAL DRUGS
7.3.1. Overview
7.3.2. Antiviral Drugs Market Forecast and Analysis
7.4. VACCINES
7.4.1. Overview
7.4.2. Vaccines Market Forecast and Analysis
7.5. CHEMOTHERAPY
7.5.1. Overview
7.5.2. Chemotherapy Market Forecast and Analysis
7.6. TARGETED THERAPY
7.6.1. Overview
7.6.2. Targeted Therapy Market Forecast and Analysis
7.7. IMMUNOSUPPRESSANT
7.7.1. Overview
7.7.2. Immunosuppressant Market Forecast and Analysis
7.8. IMMUNOGLOBULINS
7.8.1. Overview
7.8.2. Immunoglobulins Market Forecast and Analysis
7.9. CORTICOSTEROIDS
7.9.1. Overview
7.9.2. Corticosteroids Market Forecast and Analysis
8. LIVER DISEASES THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. ADULT LIVER DISEASE TREATMENT CENTER
8.4.1. Overview
8.4.2. Adult Liver Disease Treatment Center Market Forecast and Analysis
8.5. AMBULATORY SURGICAL CENTER
8.5.1. Overview
8.5.2. Ambulatory Surgical Center Market Forecast and Analysis
9. LIVER DISEASES THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Liver Diseases Therapeutics Market Overview
9.1.2 North America Liver Diseases Therapeutics Market Forecasts and Analysis
9.1.3 North America Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.1.4 North America Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.1.5 North America Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Liver Diseases Therapeutics Market
9.1.5.1.1 United States Liver Diseases Therapeutics Market by Type of Treatment
9.1.5.1.2 United States Liver Diseases Therapeutics Market by End user
9.1.5.2 Canada Liver Diseases Therapeutics Market
9.1.5.2.1 Canada Liver Diseases Therapeutics Market by Type of Treatment
9.1.5.2.2 Canada Liver Diseases Therapeutics Market by End user
9.1.5.3 Mexico Liver Diseases Therapeutics Market
9.1.5.3.1 Mexico Liver Diseases Therapeutics Market by Type of Treatment
9.1.5.3.2 Mexico Liver Diseases Therapeutics Market by End user
9.2. EUROPE
9.2.1 Europe Liver Diseases Therapeutics Market Overview
9.2.2 Europe Liver Diseases Therapeutics Market Forecasts and Analysis
9.2.3 Europe Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.2.4 Europe Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.2.5 Europe Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Liver Diseases Therapeutics Market
9.2.5.1.1 Germany Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.1.2 Germany Liver Diseases Therapeutics Market by End user
9.2.5.2 France Liver Diseases Therapeutics Market
9.2.5.2.1 France Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.2.2 France Liver Diseases Therapeutics Market by End user
9.2.5.3 Italy Liver Diseases Therapeutics Market
9.2.5.3.1 Italy Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.3.2 Italy Liver Diseases Therapeutics Market by End user
9.2.5.4 Spain Liver Diseases Therapeutics Market
9.2.5.4.1 Spain Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.4.2 Spain Liver Diseases Therapeutics Market by End user
9.2.5.5 United Kingdom Liver Diseases Therapeutics Market
9.2.5.5.1 United Kingdom Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.5.2 United Kingdom Liver Diseases Therapeutics Market by End user
9.2.5.6 Rest of Europe Liver Diseases Therapeutics Market
9.2.5.6.1 Rest of Europe Liver Diseases Therapeutics Market by Type of Treatment
9.2.5.6.2 Rest of Europe Liver Diseases Therapeutics Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Liver Diseases Therapeutics Market Overview
9.3.2 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.3.4 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Liver Diseases Therapeutics Market
9.3.5.1.1 Australia Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.1.2 Australia Liver Diseases Therapeutics Market by End user
9.3.5.2 China Liver Diseases Therapeutics Market
9.3.5.2.1 China Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.2.2 China Liver Diseases Therapeutics Market by End user
9.3.5.3 India Liver Diseases Therapeutics Market
9.3.5.3.1 India Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.3.2 India Liver Diseases Therapeutics Market by End user
9.3.5.4 Japan Liver Diseases Therapeutics Market
9.3.5.4.1 Japan Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.4.2 Japan Liver Diseases Therapeutics Market by End user
9.3.5.5 South Korea Liver Diseases Therapeutics Market
9.3.5.5.1 South Korea Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.5.2 South Korea Liver Diseases Therapeutics Market by End user
9.3.5.6 Rest of Asia-Pacific Liver Diseases Therapeutics Market
9.3.5.6.1 Rest of Asia-Pacific Liver Diseases Therapeutics Market by Type of Treatment
9.3.5.6.2 Rest of Asia-Pacific Liver Diseases Therapeutics Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Liver Diseases Therapeutics Market Overview
9.4.2 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.4.4 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Liver Diseases Therapeutics Market
9.4.5.1.1 South Africa Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.1.2 South Africa Liver Diseases Therapeutics Market by End user
9.4.5.2 Saudi Arabia Liver Diseases Therapeutics Market
9.4.5.2.1 Saudi Arabia Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.2.2 Saudi Arabia Liver Diseases Therapeutics Market by End user
9.4.5.3 U.A.E Liver Diseases Therapeutics Market
9.4.5.3.1 U.A.E Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.3.2 U.A.E Liver Diseases Therapeutics Market by End user
9.4.5.4 Rest of Middle East and Africa Liver Diseases Therapeutics Market
9.4.5.4.1 Rest of Middle East and Africa Liver Diseases Therapeutics Market by Type of Treatment
9.4.5.4.2 Rest of Middle East and Africa Liver Diseases Therapeutics Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Liver Diseases Therapeutics Market Overview
9.5.2 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis - By Type of Treatment
9.5.4 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis - By End user
9.5.5 South and Central America Liver Diseases Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Liver Diseases Therapeutics Market
9.5.5.1.1 Brazil Liver Diseases Therapeutics Market by Type of Treatment
9.5.5.1.2 Brazil Liver Diseases Therapeutics Market by End user
9.5.5.2 Argentina Liver Diseases Therapeutics Market
9.5.5.2.1 Argentina Liver Diseases Therapeutics Market by Type of Treatment
9.5.5.2.2 Argentina Liver Diseases Therapeutics Market by End user
9.5.5.3 Rest of South and Central America Liver Diseases Therapeutics Market
9.5.5.3.1 Rest of South and Central America Liver Diseases Therapeutics Market by Type of Treatment
9.5.5.3.2 Rest of South and Central America Liver Diseases Therapeutics Market by End user
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. LIVER DISEASES THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTELLAS PHARMA INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BRISTOL-MAYERS SQUIBB
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GILEAD SCIENCES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MERCK AND CO., INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SANOFI S.A.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PFIZER INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS